Ardelyx, Inc. (ARDX): Net Income
-$61.60M
Year ended 2025-12-31
-$55.70M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$61.60M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$39.14M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$66.07M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$67.21M | n/m | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | -$158.16M | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | -$94.31M | n/m | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | -$94.94M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$91.30M | n/m | 2021-03-08, From 2018-01-01 |
| 2017-12-31 | -$64.34M | n/m | 2020-03-06, From 2017-01-01 |
| 2016-12-31 | -$112.39M | n/m | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | -$29.62M | n/m | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | -$3.21M | n/m | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | -$6.56M | n/m | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | -$9.79M | n/a | 2015-03-05, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$61.60M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $271.17M | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$198.84M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$16.14M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$175.54M | n/m |
| MannKind Corp (MNKD) | 2025-12-31 | $5.86M | -78.7% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $20.45M | +159.1% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$25.55M | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$732.94M | n/m |
Compare ARDX, INVA, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗